Through our regular conferences and workshops, we bring together stakeholders in childhood cancer treatment and research to exchange knowledge and ideas.
We aim to provide a forum for clinicians, scientists and other stakeholders to discuss and debate key themes, share knowledge and develop new collaborations.
We are delighted to announce that our annual Childhood Cancer 2019 conference will be hosted by Newcastle University on 9-10th September 2019. The programme will include keynote lectures, disease specific updates, proffered talks and poster presentations covering the full range of childhood & TYA cancers. Clinicians, researchers, oncology nurses, clinician scientists and students will find great value in attending and participating in this event. Details of how to register and submit abstracts will be available in early April 2019.Read more
Osteosarcoma is a long way behind other cancers in terms of new treatments and improvement in survival due to a lack of research investment.
However, the International Osteosarcoma Research Symposium 2019, hosted by Children with Cancer UK and the Bone Cancer Research Trust, brought together researchers from across the globe to identify research progress, challenges that need to be overcome and opportunities to move research forward.
This year Children with Cancer UK will be committing £500,000 to osteosarcoma research. The Bone Cancer Research Trust launched a £450,000, UK-wide observational clinical trial for all ages.Read more
12th-14th September, Westminster
A Holistic Approach to Precision Medicine, a landmark conference examining the way we understand cancer
This conference explored the way forward within the full US NIH definition of Precision Medicine.
Venue – Church House Conference Centre, Westminster
Childhood and TYA Cancer 2017 was a two-day medical, scientific and educational meeting exploring the latest state-of-the-art translational science being (and to be) used in the diagnosis and treatment of cancer in children and young people.
We had platform presentations by leading-edge clinicians and researchers and we welcomed the submission of poster presentations from researchers working in these areas of translational and precision medicine.
The Royal College of Paediatrics and Child Health approved CPD points for this conference.
5th to 7th September 2016 at Church House Conference Centre, London
We were joined by an outstanding line-up of speakers from the UK, Europe and the US to examine three themes over the three days of the conference:
Is precision medicine a reality for children with cancer in 2016?
Can we harness the power of the immune system to cure childhood cancer?
What do we know about influenceable causes of childhood cancer?
The format of the meeting was designed to facilitate the sharing of information and knowledge, providing a forum for the discussion of important issues, networking and the development of new collaborations.
In total, around 150 delegates and speakers participated in the meeting over the three days and we achieved our aim of bringing together a broad range of scientists and clinicians from different areas of childhood cancer research and care.
This workshop, chaired by Professor David Walker, was developed to highlight the priority of drug delivery research and clinical trials as part of initiatives to improve outcomes for children with brain tumours.
We wanted to identify areas of pre-clinical and clinical research that can be pursued now, with a view to early translation into clinical trials, to identify drug delivery strategies holding promise for future deployment and to identify optimal development pathways for their translation to clinical trials.
With colleagues joining us from the US, Canada and Europe to share their expertise and experience, we enjoyed two days of lively discussion.
This Think Tank brought together world experts on leading-edge aspects of the interaction of magnetic fields with biological systems to brainstorm candidate mechanisms.
Think tank report
This two-day international workshop set out to examine aspects of in utero exposure to agents that may affect subsequent cancer risk in children, with an emphasis on mechanisms of transplacental transfer and early biological effects.In utero exposure and cancer in children report
In April 2012 over 150 participants from around the world joined us in London for Childhood Cancer 2012, our international scientific conference on the causes of childhood cancer.
Over the three days that followed, delegates heard from more than 20 international experts speaking across a wide-range of topics relevant to the causes of childhood cancer including air pollution, parental smoking, pesticide exposure, genetics and diet.
For some time, exposure to infection has been implicated as a cause of childhood leukaemia, but no specific ...Read more
Children affected by the brain tumour known as ACP can have a positive future, but in many cases ...Read more